Proliferative capacity in head and neck cancer

Head and Neck

Volumn 23, Issue 6, 2001, Pages 484-491

  Struikmans, Henk ^a   Kal, Henk B ^a   Hordijk, Gert J ^a   Van Der Tweel, Ingeborg ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

DNA ploidy; Flow cytometry; Head and neck tumors; Proliferative capacity; Tumor site

Indexed keywords

BROXURIDINE;

ADULT; ANEUPLOIDY; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM STAGING; PLOIDIES; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE;

EID: 0035002368     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.1064     Document Type: Article

References (43)

1. Radiation therapy in head and neck cancer: Indication and limitation
2. Radiation therapy for head and neck neoplasms: Indications, techniques and results
3. The long term outcome after radical radiotherapy for advanced head and neck cancer
4. Accelerated fractionation radiotherapy for advanced head and neck cancer
5. Fast neutron therapy for squamous cell carcinoma in the head and neck region. Results of a randomized trial
6. In vivo measurement of the potential doubling time by flow cytometry in oropharyngeal cancer treated by conventional radiotherapy
7. Cell repopulation and overall treatment time
8. The hazard of accelerated tumor clonogen repopulation during radiotherapy
9. Rapid repopulation in radiotherapy: Debate on mechanisms, the phantom of tumor treatment - Continually rapid repopulation unmasked
10. Repopulation during radical radiotherapy for T1 glottic cancer
11. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks
12. Prospective evaluation of cell kinetics in head and neck squamous carcinoma: The relationship to tumour factors and survival
13. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen
14. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy
15. Interrelationships of DNA-ploidy and cell proliferation markers with T-stage and N-stage in primary laryngeal tumors
16. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: A multicenter analysis
17. The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: Prognostic factors
18. Flow cytometric quantification of the proliferation associated nuclear antigen p105 and DNA content in advanced head & neck cancers: Results of RTOG 91-08
19. An improved method for the immunocytochemical detection of bromodeoxyuridine labelled nuclei using flow cytometry
20. An iterative method of analysis for DNA histograms
21. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumours: An interim report
22. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers
23. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - Report on 3-year tumour control and normal tissue toxicity
24. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
25. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer
26. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
27. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumour front grading and proliferation markers
28. Tumour proliferation assessed by combined histological and flow cytometric analysis: Implication for therapy in squamous cell carcinoma in the head and neck
29. Proliferative characteristics of head and neck tumours. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry
30. Prognostic implications of nuclear DNA content in head and neck cancer
31. Squamous cell carcinoma of the oral cavity. A review of 176 cases with application of malignancy grading and DNA measurements
32. Prognostic importance of cellular DNA content in head-and-neck squamous-cell cancers. A comparison of retrospective and prospective series
33. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the head and neck region
34. Predicting radio-resistance in early glottic squamous cell carcinoma of DNA content
35. Relationship between histological features, DNA flow cytometry and clinical behavior of squamous cell carcinoma of the larynx
36. Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis
37. Ploidy status and the response of T1 glottic carcinoma to radiotherapy
38. DNA flow cytometry in advanced laryngeal cancer
39. DNA quantitation and histological characteristics of squamous cell carcinoma of the upper aerodigestive tract
40. DNA content and regional metastases in patients with advanced laryngeal squamous carcinoma
41. 0 laryngeal squamous cell carcinomas treated with radiotherapy
42. The relevance of DNA index and proliferation rate in the grading of benign and malignant soft tissue tumours
43. The predictive value of tumour-cell kinetic parameters in radiotherapy: Considerations regarding data production and analysis